Alpha IVF Group Berhad is a prominent figure in the field of fertility care, commanding a significant presence across Malaysia and Singapore. Specializing in Assisted Reproductive Services (ARS), particularly In-vitro Fertilisation (IVF), the company has established itself as a leader in the field.

The company has earned a strong reputation for exceptional success rates in fertility treatments, attracting patients from countries such as Indonesia, China, Australia, Singapore and more. This success is attributed to its team of leading medical specialists, skilled embryologists, ongoing research and development, innovative techniques, and state-of-the-art laboratory equipment.

Financially, Alpha IVF Group Berhad reported a total revenue of RM167.6 million for the financial year ending 31 May 2024, with profit after tax achieving RM52.9 million. In Q1 FY2025, Alpha IVF Group Berhad further extended their growth with revenue of RM43.0 million and profit after tax of RM14.4 million.

Demonstrating a commitment to shareholder returns, the company has a policy to distribute at least 60% of its annual audited profit after taxation attributable to shareholders.

For the financial year ended 31 May 2024, Alpha IVF Group Berhad declared a single-tier interim dividend of 0.45 sen per ordinary share, with an ex-date of 30 July 2024 and a payment date of 15 August 2024.

Subsequently, on 3 December 2024, the company announced another single-tier interim dividend of 0.5 sen per ordinary share for the financial year ending 31 May 2025, with an ex-date of 17 December 2024 and a payment date of 31 December 2024.

This increase reflects the company's ongoing commitment to providing substantial returns to its shareholders.

With its exceptional success rates in fertility treatments, a well-established brand name recognised regionally, robust financial growth, and a yield-accretive profile demonstrated by its consistent and generous dividend payouts, Alpha IVF Group Berhad stands out as a compelling addition to any investment portfolio.

The company’s strategic focus on innovation and excellence, coupled with its unwavering commitment to rewarding shareholders, positions it as a prime investment choice for those seeking a blend of stability and growth potential.